Imirestat
Alternative Names: AL 01576; AL 1576; HOE 843Latest Information Update: 15 Apr 2019
At a glance
- Originator Alcon
- Class Antihyperglycaemics; Fluorenes; Hydantoins; Small molecules
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic complications
Most Recent Events
- 09 Apr 2019 Novartis completed the spin-off of Alcon
- 28 May 2002 Discontinued - Phase-III for Diabetic complications in USA (PO)
- 22 May 2001 Profile reviewed but no significant changes made